HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of synthetic monocyte chemotactic protein-1 fragment 65-76 on neointima formation after carotid artery balloon injury in rats.

Abstract
The effects of the synthetic monocyte chemotactic protein-1 (MCP-1) peptide fragment 65-76 (peptide X) on the development of neointima after balloon injury to the carotid artery were studied. The agent was given i.m. at a dose of 33 microg/kg once daily for 28 days after balloon injury. Animals given peptide showed significant suppression of neointima growth 4 and 7 days after lesioning, as indicated by morphometric analysis of sections of lesioned arteries. On days 14 and 28, there were no significant differences in neointima formation in rats given and not given peptide. Peptide administration was not accompanied by any changes in C-reactive peptide concentrations, leukocyte counts, or the population composition of peripheral blood lymphocytes. Use of synthetic peptide X as an inhibitor of leukocyte migration during angioplasty may, along with traditional treatments, decrease the risk of restenosis.
AuthorsN B Kukhtina, P P Bashtrykov, Zh D Bespalova, M V Sidorova, T I Aref'eva, V O Sokolov, T L Krasnikova
JournalNeuroscience and behavioral physiology (Neurosci Behav Physiol) Vol. 39 Issue 2 Pg. 153-9 (Feb 2009) ISSN: 0097-0549 [Print] United States
PMID19140000 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ccl2 protein, rat
  • Chemokine CCL2
  • Peptides
  • C-Reactive Protein
Topics
  • Animals
  • C-Reactive Protein (analysis)
  • Carotid Arteries (metabolism, pathology)
  • Carotid Artery Injuries (blood, drug therapy)
  • Chemokine CCL2 (pharmacology)
  • Graft Occlusion, Vascular (prevention & control)
  • Leukocyte Count
  • Male
  • Peptides (pharmacology)
  • Rats
  • Rats, Wistar
  • Tunica Intima (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: